The evolving role of the optometrist in nonsurgical cataract management
Optometry 360
Home > Myopia control lenses effective at 12 months but uncertain at 24 months

Myopia control lenses effective at 12 months but uncertain at 24 months

Kelsey Moroz

Spectacle lenses designed to control myopia progression show significant short-term benefits in reducing myopia progression at 12 months but lack clear long-term efficacy at 24 months, according to a study.

This systematic review analyzed 21 studies, with 17 contributing data for meta-analysis. The study analyzed outcomes at 12- and 24-month intervals using data from 6,175 participants.

At 12 months, the lenses significantly reduced myopia progression, with a pooled effect size showing improvements in spherical equivalent refraction, axial length (P < 0.0001). However, at 24 months, these benefits were not statistically significant. Relative peripheral refraction results varied across lens models.

The findings suggest that while these lenses offer short-term benefits, their long-term efficacy remains unclear.

Reference
Perea-Romero J, Signes-Soler I, Badenes-Ribera L, et al. Efficacy of spectacle lenses specifically designed for myopia control: systematic review and meta-analysis. Graefes Arch Clin Exp Ophthalmol. 2024;doi: 10.1007/s00417-024-06706-4. Epub ahead of print. PMID: 39652182.

Related Content